• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, October 9, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

Robots and A.I. team up to discover highly selective catalysts

Bioengineer by Bioengineer
February 3, 2023
in Chemistry
Reading Time: 3 mins read
0
The semi-automated synthesis robot
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Researchers used a chemical synthesis robot and computationally cost effective A.I. model to successfully predict and validate highly selective catalysts.

The semi-automated synthesis robot

Credit: ICReDD

Researchers used a chemical synthesis robot and computationally cost effective A.I. model to successfully predict and validate highly selective catalysts.

Artificial intelligence (A.I.) has made headlines recently with the advent of ChatGPT’s language processing capabilities. Creating a similarly powerful tool for chemical reaction design remains a significant challenge, especially for complex catalytic reactions. To help address this challenge, researchers at the Institute for Chemical Reaction Design and Discovery and the Max Planck Institut für Kohlenforschung have demonstrated a machine learning method that utilizes advanced yet efficient 2D chemical descriptors to accurately predict highly selective asymmetric catalysts—without the need for quantum chemical computations.  

“There have been several advanced technologies which can “predict” catalyst structures, but those methods often required large investments of calculation resources and time; yet their accuracy was still limited,” said joint first author Nobuya Tsuji. “In this project, we have developed a predictive model which you can run even with an everyday laptop PC.”

For a computer to learn chemical information, molecules are usually represented as a collection of descriptors, which often consist of small parts, or fragments, of those molecules. These are easier for A.I. to process and can be arranged and rearranged to construct different molecules, much like Lego pieces can be arranged and connected in different ways to construct different structures. 

However, computationally cheaper 2D descriptors have struggled to accurately represent complex catalyst structures, leading to inaccurate predictions. To improve this issue, researchers developed new Circular Substructure (CircuS) 2D descriptors that explicitly represent cyclic and branched hydrocarbon structures, which are common in catalysis. Training data for the A.I. was obtained through experiments via a streamlined, semi-automatic process utilizing a synthesis robot. This experimental data was then converted into descriptors and used to train the A.I. model.

Researchers used the fully trained model to virtually test 190 catalysts not part of the training data. In this set, the A.I. model was able to predict highly selective catalysts after only having been trained on the data of catalysts with moderate selectivity, showing an ability to extrapolate beyond the training data. The catalyst predicted to have the highest selectivity was then tested experimentally, exhibiting a selectivity nearly identical to that predicted by the A.I. model. Obtaining high selectivity is especially crucial for the design of new medicines, and this technique provides chemists with a powerful framework for optimizing selectivity that is efficient in both computational and labor cost.

“Often, to predict new selective catalysts chemists would use models based on quantum chemical calculations. However, such models are computationally costly, and when the number of compounds and the size of molecules increases, their application becomes limited,” commented joint first author Pavel Sidorov. “Models based on 2D structures are much cheaper and therefore can process hundreds and thousands of molecules in seconds. This allows chemists to filter out the compounds they may not be interested in much more quickly.”



Journal

Angewandte Chemie International Edition

DOI

10.1002/anie.202218659

Method of Research

Experimental study

Subject of Research

Not applicable

Article Title

Predicting highly enantioselective catalysts using tunable fragment descriptors

Article Publication Date

23-Jan-2023

Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Transforming Bioplastics: Microbial Innovation Enables Fully Bio-Based Long-Chain Polyesters

October 9, 2025
blank

Tracking Bandgap Dynamics in Real Time: Attosecond Interferometry Unveils Ultrafast Processes in Solids

October 9, 2025

Streamlined Ion Diffusivity Calculations with FastTrack: Simplifying Breakthroughs in Science

October 9, 2025

Targeted Boron-Heteroatom Group Exchange Reactions Unveiled

October 9, 2025

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1173 shares
    Share 468 Tweet 293
  • New Study Reveals the Science Behind Exercise and Weight Loss

    101 shares
    Share 40 Tweet 25
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    96 shares
    Share 38 Tweet 24
  • Ohio State Study Reveals Protein Quality Control Breakdown as Key Factor in Cancer Immunotherapy Failure

    81 shares
    Share 32 Tweet 20

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Urological Models Verified with Human Penile Tissue Tests

Emergency Nurses’ Presenteeism: A Qualitative Insight

Enhancing Care Quality with WHO SMART Guidelines

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 63 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.